is trulicity a glp-1 inhibitor Evolution of GLP‐1 Receptor Agonists for Diabetes Treatment List of approved and pending

Side Effects: Nausea, dizziness, fatigue, and impulse control disorders (e.g., compulsive gambling or shopping)

In the Metformin in Gestational Diabetes (MiG) trial published in 2008, in which patients were randomized to insulin versus metformin, there was a signal that there was an increased risk for elevated BMI and childhood overweight later in life at age 7 to 9 years in one of the cohorts

Obesity segment growing at the fastest CAGR

However, in a dose-dependent manner, its combination with acrylamide led to the significant elevation of the number of ovarian follicles and the levels of FSH, E2 and progesterone (Reference Naimi, Shariati and Naimi31)